Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-30
1991-02-19
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514273, 514275, 544295, 544320, 544321, 544330, 544331, 544332, A61K 31495, C07D40304
Patent
active
049944606
ABSTRACT:
A series of 5-halopyrimidin-2-ylpiperazinylalkyl derivatives having useful anti-ischemic properties for treatment and prevention of dirorders resulting from brain and/or spinal cord anoxia.
REFERENCES:
patent: 2973360 (1961-02-01), Janssen et al.
patent: 3299067 (1967-01-01), Regnier et al.
patent: 3808210 (1974-04-01), Regnier et al.
patent: 4316899 (1982-02-01), Markwell
patent: 4605655 (1986-08-01), Yevich et al.
patent: 4711899 (1987-12-01), Gaudillier
patent: 4857644 (1989-08-01), Abou-Gharbia
Regnier et al, "Chemical Abstracts", vol. 70, 1969, col. 11717k.
Yevich, et al., "Chemical Abstracts", vol. 104, 1986, col. 109686v.
Gotti, et al., JPET, 247/3, pp. 1211-1221; (1988) (4/9).
Wauquier, et al., in "Drug Development Research", 8, pp. 373-380; (4/14).
Dextraze Pierre
Yevich Joseph P.
Bristol-Myers Squibb Co.
Hollrah Glennon H.
Ryan Richard P.
Turnipseed James H.
LandOfFree
Agents for treatment of brain ischemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents for treatment of brain ischemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for treatment of brain ischemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143827